van Leth, F., Günther, G., Hoffmann, H., Lange, C., Alexandru, S., Altet, N., . . . Viiklepp, P. (2017). Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria. American journal of respiratory and critical care medicine, 196(11), 1489-1490. https://doi.org/10.1164/rccm.201705-0995LE
Chicago-Zitierstil (17. Ausg.)van Leth, Frank, et al. "Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria." American Journal of Respiratory and Critical Care Medicine 196, no. 11 (2017): 1489-1490. https://doi.org/10.1164/rccm.201705-0995LE.
MLA-Zitierstil (9. Ausg.)van Leth, Frank, et al. "Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria." American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 11, 2017, pp. 1489-1490, https://doi.org/10.1164/rccm.201705-0995LE.